ZACHARY KOPECKY: Open Payments
NPI 1730859992 · CASA GRANDE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,496 in 176 payments from 26 companies in 2025. Trend: 2023 $777 · 2024 $3,480 · 2025 $3,496
Food & beverage: $3,345Education: $117Speaker / faculty: $34
| Company | Payments | Amount |
|---|---|---|
| Travere Therapeutics, Inc. | 11 | $420 |
| AstraZeneca Pharmaceuticals LP | 11 | $382 |
| Amgen Inc. | 29 | $371 |
| Bayer Healthcare Pharmaceuticals Inc. | 23 | $363 |
| Daiichi Sankyo Inc. | 19 | $255 |
| Novartis Pharmaceuticals Corporation | 16 | $252 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 15 | $232 |
| AKEBIA THERAPEUTICS INC | 5 | $203 |
| Otsuka America Pharmaceutical, Inc. | 12 | $164 |
| OPKO Pharmaceuticals, LLC | 6 | $117 |
Products named: Kerendia, JARDIANCE, INJECTAFER, LOKELMA, Vafseo, KRYSTEXXA, JYNARQUE, Fabhalta.
Industry payments across AZ — which companies pay providers there.
